Chen-Sheng Lin

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

Scott Antonia, José A. López-Martín, Johanna C. Bendell et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

Padmanee Sharma, Margaret K. Callahan, Petri Bono et al. · The Lancet Oncology · 2016 · 685 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63

Jing‐Ru Weng, Chen-Sheng Lin, Hsueh‐Chou Lai et al. · Virus Research · 2019 · 170 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +9

Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan

Su‐Hua Huang, Mei-Chi Su, Ni Tien et al. · Journal of Microbiology Immunology and Infection · 2015 · 44 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +17

Bayesian Survival Analysis With Nonproportional Hazards

Scott Berry, Donald A. Berry, Kannan Natarajan et al. · Journal of the American Statistical Association · 2004 · 40 citations

Public Health, Biostatistics, Pharmacology +12